This is just a glimpse. Want to receive every issue of Cannabis Wire Daily, our newsletter that is sent to subscribers each weekday morning, and unlimited access to cannabiswire.com?
Ohio’s proposed adult use rules are here
Ohio’s Division of Cannabis Control has taken the first big step toward meeting its September 7 deadline to start issuing provisional licenses for adult use businesses in the state.
On Monday, the Division released its package of proposed rules, which focus on getting the ball rolling for adult use sales via existing medical cannabis businesses.
Future licensing rounds are TBD. All the regulations say on equity licensing, for example, is that in “coordination with the department of development cannabis social equity jobs program, the division shall provide notice in advance of an application period for which preference shall be given to applicants certified as cannabis social equity and jobs program participants.”
To refresh: voters approved adult use at the ballot box in November, as Cannabis Wire reported at the time, and legal home grow and possession went into effect in December.
Cannabis workers get two victories.
Late last week, in two different states, cannabis workers seeking union representation got some good news.
In Arizona, on Thursday, workers in Trulieve’s production site in Phoenix (including those within “cultivation” and “post-harvest” departments) voted to join the United Food and Commercial Workers Union (UFCW)Local 99. The election was overseen by the Arizona Agriculture Labor Relations Board, a first for workers in the state’s cannabis industry.
In Missouri, the National Labor Relations Board decided that “Post-Harvest” employees at BeLeaf Medical, which has three grow sites and five shops, could vote to join the United Food and Commercial Workers Local 655.
BeLeaf argued that its “Packaging” workers are “Harvest Technicians and Post-Harvest Technicians,” and therefore exempt from the National Labor Relations Act. (This is usually the case for ag workers, which makes the aforementioned development in Arizona particularly noteworthy.) NLRB disagreed, and an election for the workers to join UFCW will take place on Feb 6.
Clinical trial will test psilocybin’s potential to treat cannabis use disorder.
McMaster University researchers are conducting a Phase 2 clinical trial on the feasibility, safety, tolerability, and potential therapeutic uses of psilocybin-assisted-psychotherapy in the treatment of cannabis use disorder.
“A review of current treatments available for [cannabis use disorder] indicate the lack of a pharmacological and psychological treatment with high success rates, which highlights the importance of exploring potential psychosocial interventions for the treatment of [cannabis use disorder,” the notice reads.
This trial will include 16 participants and is expected to wrap up in 2026.
The Center for Medicinal Cannabis Research at UC San Diego is a collaborator.